Thalidomide and the Titanic

The Titanic has become a metaphor for the disastrous consequences of an unqualified belief in the safety and invincibility of new technology. Similarly, the thalidomide tragedy stands for all of the "monsters" that can be inadvertently or negligently created by modern medicine. Thalidomide, once banned, has returned to the center of controversy with the Food and Drug Administration's (FDA's) announcement that thalidomide will be placed on the market for the treatment of erythema nodosum leprosum, a severe dermatological complication of Hansen's disease. Although this indication is very restricted, thalidomide will be available for off-label uses once it is on the market. New laws regarding abortion and a new technology, ultrasound, make reasonable the approval of thalidomide for patients who suffer from serious conditions it can alleviate. In addition, the FDA and the manufacturer have proposed the most stringent postmarketing monitoring ever used for a prescription drug, including counseling, contraception, and ultrasonography in the event of pregnancy. The Titanic/thalidomide lesson for the FDA and public health is that rules and guidelines alone are not sufficient to guarantee safety. Continuous vigilance will be required to ensure that all reasonable postmarketing monitoring steps are actually taken to avoid predictable and preventable teratogenic disasters

Adverse effect · Drug · Food and drug administration · Intensive care medicine · Medical emergency · Multiple myeloma · Pharmacovigilance · Postmarketing surveillance · Psychiatry · Thalidomide · Medicine · Pharmacology · Pregnancy and Medication Impact · Reproductive Health and Contraception · Systemic Lupus Erythematosus Research

• Healthy Public Relations

  Gwen Kay•Bulletin of the history of medicine•2001

  Incluir item

• Epidemiology of birth defects based on surveillance data from 2011–2015 in Guangxi, China

  Open Access•Jichang Chen, Xu-Feng Huang et al.•BMC Public Health•2018

  Incluir item

• The Submissive Relationship of Public Health to Government, Politics, and Economics

  Open Access•Daniel Peplow, Sarah Augustine•International Journal of…•2020

  Incluir item

• Boon or bust? Heidegger, disability aesthetics and the thalidomide memorial

  Thomas Abrams•Disability & Society•2013

  Incluir item

• American Medicine as Religious Practice

  Open Access•Margaret P Wardlaw•Journal of Religion and Health•2011

  Incluir item

• Heidegger, subjectivity, disability

  Open Access•Thomas Abrams•Subjectivity•2015

  Incluir item

• The Experience of Death in Techno-Scientific Societies

  Open Access•Noelia Bueno Gómez•Illness Crisis & Loss•2017

  Incluir item

• Ethical Issues in Human Population Biology

  Open Access•T R Turner•Current Anthropology•2012

  Incluir item

• The broader message of accutane

  S R Shulman, Sheila Shulman•American Journal of Public Health•1989

  Incluir item